Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for Metabolic disorders: SNAI increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of  Interleukin-22, 26/October/2014, 13.12, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: An insight into how SNAI increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia.

Significance: This study suggests, for the first time, that SNAI, by increasing the expression of IL-22, it may increase insulin sensitivity, restore gut immunity and decrease endotoxaemia. Together, this study suggests that pharmacological formulations encompassing “SNAI activators” may be used to treat metabolic disorders, including T2DM and cardiac diseases.

Spread the love